fsp1 is a glutathione

fsp1 is a glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 FSP1, a key ferroptosis suppressor

Name: fsp1 is a glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 FSP1, a key ferroptosis suppressor
Brand: southroadsurgery.com.au
SKU: 69288103737
Price: 24.03 USD
Availability: InStock
Rating: 4.6021 (12 reviews)

FSP1, a key ferroptosis suppressor with therapeutic potential ScienceDirect Schematic description of regulatory pathways in ferroptosis. GSH, Download Scientific Diagram FSP1 is a glutathione independent ferroptosis suppressor Nature iFSP1 is a Selective FSP1 Inhibitor Glutathione Independently Network of Cancer Research Ferroptosis inhibitors: mechanisms of action and therapeutic potential Cellular and Molecular Life Sciences Springer Nature Link Molecular mechanisms of FSP1 regulated ferroptosis and therapeutic implications in various cancers Cellular & Molecular Biology Letters Springer Nature Link

SKU: 69288103737 · From southroadsurgery.com.au

4.6

USD24.03 USD46.03

Pay in 4 interest-free payments of $6.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Description

Vitamin B12 Deficiency and the Nervous System: Beyond Metabolic DecompensationComparing Biological Models and Gaining New Insights into Molecular and Cellular Mechanisms

Melatonin improves ischemia-induced circulation recovery impairment in mice with streptozotocin-induced diabetes by improving the endothelial progenitor cells functioning

This is especially useful for compounds such as siRNA, miRNA and chemotherapeutic agents that need to act on the target at a site in order to reduce off-target effects

Gastroenterology 136 , 15851592 (2009)

In addition, Wang et al., using organic proteomics and metabolomics approaches, identified a new mitochondrial transporter, SLC25A39, and highlighted its essential role in proliferation

Furthermore, dynamic monitoring of these biomarkers holds promise for elucidating the role of cuproptosis in disease progression, particularly in patients refractory to standard therapies